Our ambition

Pave the way for a truly personalized approach in cancer.

 

 READ MORE

Translational biomarker approaches
to address patient needs

Pharmaco-imaging in support of therapeutic development

and for drug targeting.

 

 

READ MORE

State-of-the-art models for optimal
predictive value

Patient-derived xenografts and human immune system

models to allow better decisions.

 

 

READ MORE

Next generation kinase inhibitors
with unique properties

Potent and selective Nanocyclix leads for known

and novel kinases.

 

 

READ MORE

We partner to advance cancer
research

Joining forces to the benefits of patients.

April 5-9, 2014
Oncodesign at AACR 2014 in San Diego (US)
Our latest developments through 4 posters, booth 2344
READ MORE
April 3, 2014
Webinar: Integrate syngeneic murine models in drug development, focus on anti-cancer immunotherapies
READ MORE

ONCOLOGY TRANSLATIONAL

EXPERIMENTATION

A large panel of technological and scientific solutions for pharmacological qualification of your compounds : a unique oncology preclinical CRO

DISCOVERY PARTNERING

 

A platform-based approach for the discovery of novel chemical entities with therapeutic and diagnostic potential